SIGN UP

February 15, 2017 10:03 AM ESTUpdated 10:44 AM

Ionis bags a $75M milestone from Bayer; Inventiva garners $51M from IPO

Shehla Shakoor

Managing Director

• Ionis Pharmaceuticals $IONS is picking up a $75 million milestone payment from Bayer related to IONIS-FXIRx. Ionis plans to start a Phase IIb …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

sponsored

Are programs with compounded GLP-1s safe for your population?